These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6107191)

  • 1. Gastric inhibitory polypeptide.
    Ebert R; Creutzfeldt W
    Clin Gastroenterol; 1980 Sep; 9(3):679-98. PubMed ID: 6107191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbances of the entero-insular axis.
    Creutzfeldt W; Ebert R; Nauck M; Stöckmann F
    Scand J Gastroenterol Suppl; 1983; 82():111-9. PubMed ID: 6356314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory effects of gastric inhibitory polypeptide on the isolated perfused porcine pancreas.
    Jensen SL; Holst JJ; Nielsen OV; Lauritsen KB
    Acta Physiol Scand; 1981 Mar; 111(3):233-8. PubMed ID: 7032210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric inhibitory polypeptide (GIP).
    Sarson DL
    J Clin Pathol Suppl (Assoc Clin Pathol); 1978; 8():31-7. PubMed ID: 399609
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical studies with gastric inhibitory polypeptide.
    Brown JC; Otte S
    World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incretin concept today.
    Creutzfeldt W
    Diabetologia; 1979 Feb; 16(2):75-85. PubMed ID: 32119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastric inhibitory polypeptide (GIP) (author's transl].
    Ebert R; Finke U
    Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
    Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
    Ross SA; Brown JC; Dupré J
    Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrointestinal hormones and related neuropeptides. IV. The secretion group: gastric inhibitory polypeptide (GIP), intestinal pancreatic glucagon-like immunoreactants (intestinal GLI) and PHI].
    Krowicki Z; Sadowska-Krowicka H; Zych F
    Postepy Hig Med Dosw; 1984; 38(4):513-34. PubMed ID: 6399110
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
    Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GIP and the entero-insular axis.
    Brown JC; Otte SC
    Clin Endocrinol Metab; 1979 Jul; 8(2):365-77. PubMed ID: 383323
    [No Abstract]   [Full Text] [Related]  

  • 14. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
    Takemura J; Seino Y; Yamamura T; Yoshiya K; Ishikawa Y; Itoh N; Imura H
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
    Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
    Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiology and pathology of the entero-insular axis].
    Creutzfeldt W
    Schweiz Med Wochenschr; 1985 Jul; 115(29):970-3. PubMed ID: 3901250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide.
    Meier JJ; Nauck MA
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):587-606. PubMed ID: 15533777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.